About the Company
Filament Health Corp
BUSINESS DESCRIPTION
We honed our expertise at Mazza Innovation, a natural extraction startup, which our team scaled from pre-seed to an exit in 2018. At Mazza, we developed and commercialized patent-protected extraction technologies at a 35,000 ft2 commercial-scale GMP facility. ..
Filament Health Corp News
-
Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health...
03/16/2026 01:00 PMWhole leaf coca extract under evaluation is Magdalena's drug candidate for post-GLP-1 weight loss management SAN FRANCISCO, CA / ACCESS Newswire / March 16, 202...
-
FILAMENT HEALTH ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS AND OPERATIONAL H...
11/07/2025 10:00 PMFilament Health Corp. (OTC: FLHLF) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, released its second quarter f...
-
FILAMENT HEALTH ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND OPERATIONAL ...
08/11/2025 11:00 AMFilament Health Corp. (OTC: FLHLF) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, released its second quarter f...
-
FILAMENT HEALTH ANNOUNCES FIRST-EVER COMPASSIONATE USE APPROVAL FOR PSILOCYBIN I...
07/31/2025 11:15 AMFilament Health Corp. (OTC:FLHLF) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced the first-ever...
-
FILAMENT HEALTH ANNOUNCES TWO PHASE 2 RESEARCH TRIALS IN PARTNERSHIP WITH UNIVER...
07/24/2025 11:15 AMFilament Health Corp. (OTC: FLHLF) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, today announced that it has p...
-
Weekly Roundup on the Cannabis Sector & Psychedelic Sector...
07/13/2025 06:35 PMKey Takeaways; Cannabis Sector TerrAscend secured $79 million debt financing amid strategic exit from Michigan Auxly Cannabis marked a major financial turning p...
-
Coca Access and Benefit Sharing Agreement Authorized by Peru's National Institut...
07/08/2025 01:00 PMMagdalena is focused on developing novel, natural prescription medicines derived from plants for mental health indications SAN FRANCISCO, CA / ACCESS Newswire /...
-
FILAMENT HEALTH ANNOUNCES FDA AUTHORIZATION OF PHASE 2 CLINICAL TRIAL STUDYING P...
07/07/2025 11:15 AMFilament Health Corp. (OTC:FLHLF) ("Filament" or the "Company"), a clinical-stage natural psychedelic drug development company, today announced that the U.S. Fo...
Disclaimer: